Promising combo targets Hard-to-Treat head and neck cancer
Disease control
Ongoing
This study tests a combination of two drugs, docetaxel and pembrolizumab, in people with head and neck cancer that has come back or spread. The goal is to see if this combo can shrink tumors better than current treatments. The trial includes 27 adults who have not had chemotherap…
Phase: PHASE2 • Sponsor: Hokkaido University Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC